Purified anti-mouse CD127 (IL-7Rα) Antibody

Pricing & Availability
Clone
A7R34 (See other available formats)
Regulatory Status
RUO
Other Names
IL-7 receptor α chain, IL-7Rα
Isotype
Rat IgG2a, κ
A_A7R34_PE_100809
C57BL/6 mouse splenocytes stained with rat IgG2a (RTK2758) PE isotype control and CD3 (145-2C11) APC
  • A_A7R34_PE_100809
    C57BL/6 mouse splenocytes stained with rat IgG2a (RTK2758) PE isotype control and CD3 (145-2C11) APC
  • B_A7R34_PE_100809
    C57BL/6 mouse splenocytes stained with A7R34 PE and CD3 (145-2C11) APC
Compare all formats
Cat # Size Price Quantity Check Availability
135002 500 µg $136.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD127 is a 60-90 kD type I transmembrane glycoprotein also known as IL-7 receptor α chain or IL-7Rα. It forms a heterodimer with the common γ chain (γc or CD132) which is shared with the receptors for IL-2, IL-4, IL-9, IL-13, IL-15, and IL-21. CD127 is expressed on immature B cells through early pre-B stage, thymocytes (except CD4/CD8 double positive thymocytes), peripheral T cells, and bone marrow stromal cells. CD127 has been reported to be an useful marker for identifying memory and effector T cells. The ligation of IL-7 with its receptor is important for stimulation of mature and immature T cells as well as immature B cells proliferation and development.

Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
IL-7Ra-IgG1 fusion protein
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IP, WB, IHC, ICC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per million cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

A7R34 is able to block clone SB/199 binding to IL-7R.

Application References

(PubMed link indicates BioLegend citation)
  1. Sudo T, et al. 1993. P. Natl. Acad. Sci. USA 90:9125.
  2. Hashi H, et al. 2001. J. Immunol. 166:3702.
  3. Taylor R, et al. 2007. J. Immunol. 178:5659.
  4. Mazzon C, et al. 2011. Blood. 118:2733. PubMed
  5. Jin J, et al. 2011. J. Immunol. doi:10.4049/jimmunol.1001238. PubMed
Product Citations
  1. Campisi L, et al. 2022. Nature. 606:945. PubMed
  2. Potempa M, et al. 2022. J Immunol. 208:1742. PubMed
  3. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  4. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  5. De Vlaeminck Y, et al. 2020. Cancers (Basel). 12:. PubMed
  6. Nguyen N, et al. 2022. iScience. 25:103679. PubMed
  7. Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
  8. Shen G, et al. 2017. Eur J Immunol. 47:900. PubMed
  9. Qin Q, et al. 2017. Virology. 502:198. PubMed
  10. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  11. Zhou D, et al. 2022. Nat Commun. 13:5174. PubMed
  12. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  13. Hsiao CC, et al. 2021. Cells. 10:. PubMed
  14. Sun Y, et al. 2020. J Immunol. 205:3358. PubMed
  15. Mazzon C, et al. 2011. Blood. 118:2733. PubMed
  16. Verbiest T, et al. 2018. Leukemia. 32:1435. PubMed
  17. Neumann K, et al. 2017. J Immunol. 198(1):128-137. PubMed
  18. Gubin MM, et al. 2018. Cell. 175:1014. PubMed
  19. Parigi SM, et al. 2018. Sci Rep. 0.440277778. PubMed
  20. Karmaus PWF, et al. 2019. Nature. 565:101. PubMed
  21. Kakaradov B, et al. 2017. Nat Immunol. 18:422. PubMed
  22. Inclan-Rico JM, et al. 2020. PLoS Pathog. 16:e1008579. PubMed
  23. Link CWM, et al. 2020. Front Immunol. 11:596772. PubMed
  24. Wagner AK, et al. 2017. Nat Commun. 8:15627. PubMed
  25. Stelekati E, et al. 2018. Cell Rep. 2.445833333. PubMed
  26. Sudan R, et al. 2022. Front Immunol. 13:830961. PubMed
  27. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  28. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  29. Maier B, et al. 2020. Nature. 580:257. PubMed
  30. An Y et al. 2018. Cell reports. 25(3):702-714 . PubMed
  31. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
  32. Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
RRID
AB_1937287 (BioLegend Cat. No. 135002)

Antigen Details

Structure
Type I transmembrane glycoprotein, associate with CD132, 60-90 kD
Distribution

Immature B cells through early pre-B stage, thymocytes (except CD4/CD8 double positive thymocytes), peripheral T cells, bone marrow stromal cells

Function
T cell and immature B cell proliferation and development
Ligand/Receptor
IL-7
Cell Type
B cells, T cells, Thymocytes
Biology Area
Immunology
Molecular Family
CD Molecules, Cytokine/Chemokine Receptors
Antigen References

1. Sudo T, et al. 1993. P. Natl. Acad. Sci. USA 90:9125.
2. Okuno Y, et al. 2001. P. Natl. Acad. Sci. USA 99:6246.
3. Pillai M, et al. 2004. Leukemia Lymphoma 45:2403.

Gene ID
16197 View all products for this Gene ID
UniProt
View information about CD127 on UniProt.org
Go To Top Version: 3    Revision Date: 01/15/2021

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Login/Register
Forgot your password? Reset Password
Request an Account